Substance / Medication

Emedastine

Overview

Active Ingredient
emedastine
RxNorm CUI
28144

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Estimation of in vivo percutaneous absorption of emedastine from bile excretion data using a deconvolution method.
Harada Shoichi, Yamashita Fumiyoshi, Hashida Mitsuru · Drug Metab Pharmacokinet · 2005
PMID: 16272750Observational
Emedastine During Pregnancy and Lactation: Emedastine Levels in Maternal Serum, Cord Blood, Breast Milk, and Neonatal Serum.
Saito Jumpei, Yakuwa Naho, Sasaki Aiko et al. · Breastfeed Med · 2020
PMID: 33035080Case Report
A sensitive nanocomposite design via carbon nanotube and silver nanoparticles: Selective probing of Emedastine Difumarate.
Imanzadeh Hamideh, Bakirhan Nurgul K, Habibi Biuck et al. · J Pharm Biomed Anal · 2020
PMID: 32014685Other
Emedastine Inhibits Th1 and Th2 Cell Differentiation Mediated by Mast Cells.
Matsui Katsuhiko, Kuroki Akari, Morishima Aya · Biol Pharm Bull · 2024
PMID: 38417904Preclinical
[Pharmacological profile and clinical efficacy of transdermal patch containing emedastine difumarate (ALLESAGATAPE)].
Tanida Norifumi, Akiyama Katsuhiko, Terahara Takaaki · Nihon Yakurigaku Zasshi · 2018
PMID: 30393257Preclinical

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Emedastine (substance)
SNOMED CT
372551003
UMLS CUI
C0064263
RxNorm CUI
28144

Clinical Data

This intervention maps to 2 entities in the Ltrl knowledge graph.

2
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.